Trevi Therapeutics, Inc. (TRVI)
NGM – Real Time Price. Currency in USD
17.88
+0.08 (0.45%)
Market open: Aug 12, 2026, 12:35 PM EDT
17.80
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
17.88
+0.08 (0.45%)
Market open: Aug 12, 2026, 12:35 PM EDT
17.80
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $54.3M significantly exceed its total debt $605.0K, ensuring strong financial flexibility
Total current assets $325.7M exceed Total current liabilities $8.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$17.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 37.28 | 6.05 | 10 | |
| Quick ratio | 37.28 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -43K | -123K | -147K | -132K | -137K |
| Operating Income | -30M | -34M | -52M | -49M | -60M |
| Net Income | -29M | -29M | -48M | -43M | -51M |
| EBITDA | -30M | -34M | -51M | -49M | -59M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -64.3 | 1.0 |
| Next quarter | N/A | -137.07 | 1.0 |
| Current year | N/A | -49.29 | 1.0 |
| Next year | N/A | -24.51 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -34.9 | -22.21 | -4.53 | 3.3 |
| Y/Y | 999 | -44.67 | -22.21 | 20.15 | 5.5 |
| 3y average | 999 | -17.92 | 1.8 | -14.17 | 3.8 |
| 5y average | 999 | -8.64 | 18.67 | -8.02 | 5.3 |
| Weighted average score | 4.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |